ESMO – European Society for Medical Oncology shared on LinkedIn:
“As the complexity of clinical research continues to increase, Fabrice Andre, ESMO President, highlights that stronger collaboration among all stakeholders is essential to improve efficiency and accelerate the delivery of innovative treatments to patients.
ESMO and ASCO perspectives on reducing clinical trial bureaucracy will be discussed in a webinar on 2 November, together with the progress achieved to date through the Streamlining Clinical Research Project Group.
- 2 November 2026, 18:30 CET
Webinar registration.”
You can also read:
Exploring ESMO and ASCO Perspectives on Reducing Clinical Trial Bureaucracy
